{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:28:51Z","timestamp":1787588931734,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsps.2016.04.024","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T13:06:43Z","timestamp":1462108003000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions \u2013 An evidence based review"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-7455","authenticated-orcid":false,"given":"Kamran Habib","family":"Awan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2016.04.024_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","article-title":"Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia","volume":"21","author":"Allam","year":"2005","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.jsps.2016.04.024_b0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the preempt 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jsps.2016.04.024_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.0007-1323.2001.01982.x","article-title":"Botulinum toxin a in the treatment of patients with Frey syndrome","volume":"89","author":"Beerens","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.aanat.2011.09.002","article-title":"The two main theories on dental bruxism","volume":"194","author":"Behr","year":"2012","journal-title":"Ann. Anat."},{"key":"10.1016\/j.jsps.2016.04.024_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12968\/denu.2006.33.3.165","article-title":"A review of the current uses of botox for dentally-related procedures","volume":"33","author":"Bhogal","year":"2006","journal-title":"Dent. Update"},{"key":"10.1016\/j.jsps.2016.04.024_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2010.04.043","article-title":"Use of botulinum toxin a for drug-refractory trigeminal neuralgia: preliminary report","volume":"111","author":"Bohluli","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.jsps.2016.04.024_b0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1044\/1092-4388(2002\/037)","article-title":"Botox treatment in adductor spasmodic dysphonia: a meta-analysis","volume":"45","author":"Boutsen","year":"2002","journal-title":"J. Speech Lang. Hear. Res."},{"key":"10.1016\/j.jsps.2016.04.024_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5688\/aj740218","article-title":"Is there time for student intellectual development and scholarly pursuits?","volume":"74","author":"Brazeau","year":"2010","journal-title":"Am. J. Pharm. Educ."},{"key":"10.1016\/j.jsps.2016.04.024_b0045","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.44.12.2262","article-title":"Laryngeal botulinum toxin injections for disabling stuttering in adults","volume":"44","author":"Brin","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jsps.2016.04.024_b0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archotol.130.12.1393","article-title":"Perceptual analyses of spasmodic dysphonia before and after treatment","volume":"130","author":"Cannito","year":"2004","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.otohns.2010.04.009","article-title":"Treatment of Frey\u2019s syndrome with botulinum toxin type b","volume":"143","author":"Cantarella","year":"2010","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-6054(03)00115-6","article-title":"Bruxism, temporo-mandibular dysfunction and botulinum toxin","volume":"46","author":"Chikhani","year":"2003","journal-title":"Ann. Readapt. Med. Phys."},{"key":"10.1016\/j.jsps.2016.04.024_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.coms.2007.12.003","article-title":"Classification, causation and treatment of masticatory myogenous pain and dysfunction","volume":"20","author":"Clark","year":"2008","journal-title":"Oral Maxillofac. Surg. Clin. North Am."},{"key":"10.1016\/j.jsps.2016.04.024_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxina (nt 201, xeomin(r), botulinum neurotoxin type a, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jsps.2016.04.024_b0075","article-title":"Botulinum toxin type a therapy for cervical dystonia","volume":"1","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jsps.2016.04.024_b0080","article-title":"Botulinum toxin type b for cervical dystonia","volume":"1","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jsps.2016.04.024_b0085","article-title":"Botulinum toxin type a therapy for blepharospasm","volume":"1","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jsps.2016.04.024_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archoto.2008.545","article-title":"Repeated botulinum toxin type a injections to treat patients with Frey syndrome","volume":"135","author":"de Bree","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stomax.2011.12.003","article-title":"Botulinum toxin a: analgesic treatment for temporomandibular joint disorders","volume":"113","author":"Denglehem","year":"2012","journal-title":"Rev. Stomatol. Chir. Maxillofac."},{"key":"10.1016\/j.jsps.2016.04.024_b0100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the preempt 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jsps.2016.04.024_b0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"Onabotulinumtoxina for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the preempt clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.jsps.2016.04.024_b0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00016489509139348","article-title":"Frey\u2019s syndrome: treatment with botulinum toxin","volume":"115","author":"Drobik","year":"1995","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.jsps.2016.04.024_b0115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1526-4610.2011.02022.x","article-title":"Insights into the mechanism of onabotulinumtoxina in chronic migraine","volume":"51","author":"Durham","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.jsps.2016.04.024_b0120","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/00005537-200410000-00033","article-title":"Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis","volume":"114","author":"Ellies","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jsps.2016.04.024_b0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.49.7.827","article-title":"Botulinum toxin treatment of hemifacial spasm","volume":"49","author":"Elston","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.jsps.2016.04.024_b0130","first-page":"271","article-title":"Double blind controlled study of botulinum toxin for blepharospasm","volume":"35","author":"Fahn","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jsps.2016.04.024_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(14)76386-X","article-title":"The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment","volume":"106","author":"Frueh","year":"1988","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jsps.2016.04.024_b0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1179\/crn.2008.017","article-title":"Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study","volume":"26","author":"Guarda-Nardini","year":"2008","journal-title":"Cranio"},{"key":"10.1016\/j.jsps.2016.04.024_b0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp.60.1.72","article-title":"Hemifacial spasm: a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom","volume":"60","author":"Illingworth","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jsps.2016.04.024_b0150","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis","volume":"307","author":"Jackson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jsps.2016.04.024_b0155","first-page":"467","article-title":"Botulinum a toxin in the treatment of blepharospasm","volume":"49","author":"Jankovic","year":"1988","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jsps.2016.04.024_b0160","first-page":"583","article-title":"Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum a toxin therapy","volume":"50","author":"Jankovic","year":"1988","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jsps.2016.04.024_b9000","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2377-11-140","article-title":"Rationale and design of a prospective study: cervical dystonia patient registry for observation of OnaBotulinumtoxinA efficacy (CD PROBE)","volume":"11","author":"Jankovic","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jsps.2016.04.024_b0170","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","article-title":"Effect of botulinum toxin-a in myofascial pain patients with or without functional disc displacement","volume":"66","author":"Kurtoglu","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0175","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","article-title":"Botulinum toxin in the treatment of tics","volume":"57","author":"Kwak","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jsps.2016.04.024_b0180","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type a for drooling in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsps.2016.04.024_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00129234-200403000-00011","article-title":"History and uses of botox (botulinum toxin type a)","volume":"9","author":"Lang","year":"2004","journal-title":"Lippincotts Case Manage."},{"key":"10.1016\/j.jsps.2016.04.024_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008626.pub2","article-title":"Botulinum toxin for subacute\/chronic neck pain","volume":"7","author":"Langevin","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jsps.2016.04.024_b0195","unstructured":"Levels of Evidence published by the Centre for Evidence-Based Medicine, University of Oxford in March 2009. The full reference is available in the following website: <http:\/\/www.cebm.net\/index.aspx?o=1025>."},{"key":"10.1016\/j.jsps.2016.04.024_b0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type a in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsps.2016.04.024_b0205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jsps.2016.04.024_b0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bjoms.2008.08.010","article-title":"Management of dystonia of the lateral pterygoid muscle with botulinum toxin a","volume":"47","author":"Mendes","year":"2009","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/mds.21304","article-title":"Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity","volume":"22","author":"Moller","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsps.2016.04.024_b0220","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/sj.eye.6702866","article-title":"Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-a (botox) to induce temporary ptosis for corneal protection","volume":"22","author":"Naik","year":"2008","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jsps.2016.04.024_b0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00106-010-2223-6","article-title":"The incidence of Frey syndrome following parotidectomy: results of a survey and follow-up","volume":"59","author":"Neumann","year":"2011","journal-title":"HNO"},{"key":"10.1016\/j.jsps.2016.04.024_b0230","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","article-title":"Injection of botulinum toxin type a (botox) into trigger zone of trigeminal neuralgia as a means to control pain","volume":"109","author":"Ngeow","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.jsps.2016.04.024_b0235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lary.21395","article-title":"Botulinu toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes","volume":"121","author":"Novakovic","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jsps.2016.04.024_b0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0030-6657(11)70637-0","article-title":"Application of botulinum toxin a in chronic intrinsic rhinitis","volume":"65","author":"Nowak","year":"2011","journal-title":"Otolaryngol. Pol."},{"key":"10.1016\/j.jsps.2016.04.024_b0245","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin b for Sialorrhea in Parkinson\u2019s disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jsps.2016.04.024_b0250","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjoto.2006.01.008","article-title":"The effect of intranasal injection of botulinum toxin a on the symptoms of vasomotor rhinitis","volume":"27","author":"Ozcan","year":"2006","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.jsps.2016.04.024_b0255","first-page":"2397","article-title":"Treatment of Frey\u2019s syndrome with botulinum toxin","volume":"90","author":"Pomprasit","year":"2007","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.jsps.2016.04.024_b0260","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","article-title":"Treatment of phonic tics in patients with Tourette\u2019s syndrome using botulinum toxin type a","volume":"24","author":"Porta","year":"2004","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jsps.2016.04.024_b0265","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/IOP.0b013e3181d8e150","article-title":"Abobotulinum toxin a (dysport) and botulinum toxin type a (botox) for purposeful induction of eyelid ptosis","volume":"26","author":"Reddy","year":"2010","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1746-160X-5-18","article-title":"Minimally invasive application of botulinum toxin a in patients with idiopathic rhinitis","volume":"5","author":"Rohrbach","year":"2009","journal-title":"Head Face Med."},{"key":"10.1016\/j.jsps.2016.04.024_b0275","first-page":"231","article-title":"Neurologic aspects of spasmodic dysphonia","volume":"19","author":"Rosenfield","year":"1990","journal-title":"J. Otolaryngol."},{"key":"10.1016\/j.jsps.2016.04.024_b0280","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00415-010-5880-1","article-title":"Evolution of dose and response to botulinum toxin a in cervical dystonia: a multicenter study","volume":"258","author":"Ruiz","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jsps.2016.04.024_b0285","first-page":"45","article-title":"Investigation of the effects of intranasal botulinum toxin type a and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia","volume":"46","author":"Sapci","year":"2008","journal-title":"Rhinology"},{"key":"10.1016\/j.jsps.2016.04.024_b0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum a toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jsps.2016.04.024_b0295","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bdj.4805863","article-title":"Temporomandibular disorders: masticatory myalgia and its management","volume":"160","author":"Solberg","year":"1986","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.jsps.2016.04.024_b0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S0022215111002581","article-title":"Botulinum toxin for Frey\u2019s syndrome: a closer look at different treatment responses","volume":"126","author":"Steffen","year":"2012","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.jsps.2016.04.024_b0305","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3109\/09638280903514697","article-title":"Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy","volume":"32","author":"Toffola","year":"2010","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.jsps.2016.04.024_b0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.wnf.0000172497.24770.b0","article-title":"Botulinum toxin an intractable trigeminal neuralgia","volume":"28","author":"Turk","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jsps.2016.04.024_b0315","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2165\/00003495-200161130-00004","article-title":"Cervical dystonia pathophysiology and treatment options","volume":"61","author":"Velickovic","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jsps.2016.04.024_b0320","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0278-2391(03)00153-8","article-title":"Type a botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity","volume":"61","author":"von Lindern","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0325","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.otohns.2008.06.031","article-title":"A comparison of the effects of botulinum toxin a and steroid injection on nasal allergy","volume":"139","author":"Yang","year":"2008","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jsps.2016.04.024_b0330","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","article-title":"Treatment of hemifacial spasm with botulinum toxin","volume":"15","author":"Yoshimura","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jsps.2016.04.024_b0335","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","article-title":"Beneficial effects of botulinum toxin type a in trigeminal neuralgia","volume":"66","author":"Zuniga","year":"2008","journal-title":"Arq. Neuropsiquiatr."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016416300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016416300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:51Z","timestamp":1736184591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016416300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1319016416300251"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2016.04.024","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions \u2013 An evidence based review","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2016.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}